Introduction of the First Gene Therapy Drug Approved by the United States for Treatment of Spinal Muscular Atrophy

Introduction of the First Gene Therapy Drug Approved by the United States for Treatment of Spinal Muscular Atrophy

LI Shuai, LI Gang, CHEN Guiliang

PDF(1778 KB)

主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255 CN 31-1243/R ZYGZEA

PDF(1778 KB)

Chinese Journal of Pharmaceuticals ›› 2020, Vol. 51 ›› Issue (11) : 1445-1453. DOI: 10.16522/j.cnki.cjph.2020.11.018

Pharmaceutical Management & Information

Introduction of the First Gene Therapy Drug Approved by the United States for Treatment of Spinal Muscular Atrophy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 51(11): 1445-1453 https://doi.org/10.16522/j.cnki.cjph.2020.11.018

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1778 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉